Related Experiment Video
Updated: Feb 17, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Metastatic melanoma of unknown primary: an unusual dermatologic presentation
Kali Morrissette1, Rene Chen1, Sarah Cater2
1Dermatology, Duke University School of Medicine, Durham, North Carolina, USA.
Abstract:
Metastatic melanoma without an identifiable primary lesion presents a unique diagnostic challenge and raises consideration of immune-mediated regression or non-cutaneous tumour origin. We describe the case of a man in his 80s diagnosed with metastatic melanoma, for whom a thorough skin examination and staging workup revealed no definitive primary lesion. Dermatologic evaluation revealed vitiligo-like depigmentation and a grey macule with clinical features suggestive of regression. While a definitive primary site could not be established, the constellation of clinical and dermatologic findings raises consideration of melanoma-associated depigmentation, an immune phenomenon in which both melanocytes and melanoma cells are targeted. This case highlights how immune-mediated mechanisms may obscure the detection of a primary lesion. Recognition of this pattern may aid in evaluating atypical presentations and contribute to the broader understanding of immune involvement in melanoma progression.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

